Physician profile
Michael G Abraham
NPI 1689791196
$48,311.43
in general payments reported to CMS, 2019-2025
23 companies · $5,933 in 2025
The $5,933 reported for 2025 was more than what 86% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $808 · 2021: $8,211 · 2022: $6,851 · 2023: $7,395 · 2024: $1,232 · 2025: $5,933.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $2,786 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,574.06 |
| Food and Beverage | $2,785.95 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $22,784.13 | 2019-2024 | Trevo, Axs Catalyst 7, Surpass Evolve |
| Penumbra, INC. | $15,071.49 | 2019-2024 | Penumbra System, Benchmark |
| Imperative Care, INC | $3,866.87 | 2020-2025 | Zoom 88-T Large Distal Platform |
| Qapel Medical INC | $2,444.38 | 2023-2025 | |
| Rapid Medical LTD | $2,089.90 | 2022-2025 | Tigertriever 17 Revascularization Device, Comaneci 17 |
| Depuy Synthes Sales INC. | $616.77 | 2022-2025 | Cerepak Uniform, Trufill |
| Route 92 Medical, INC. | $316.00 | 2022-2024 | 8f Base Camp Sheath System |
| Microvention, INC. | $293.92 | 2019 | |
| Microtransponder, INC. | $189.88 | 2023-2024 | |
| Medtronic, INC. | $161.57 | 2023 | Pipeline |
| Medtronic USA, INC. | $123.80 | 2019 | |
| Genentech, INC. | $76.68 | 2019 | |
| Cordis US Corp. | $51.12 | 2021-2022 | |
| Trisalus Life Sciences, INC. | $46.93 | 2025 | Trinav Infusion System |
| Inspiremd LTD | $32.68 | 2025 | Cguard Prime Carotid Stent System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amylyx Pharmaceuticals, INC. | $27.03 | 2023 | Relyvrio |
| Csl Behring | $25.44 | 2023 | Hizentra |
| Genzyme Corporation | $21.38 | 2023 | |
| Ucb, INC. | $19.30 | 2023 | |
| Abbvie INC. | $19.04 | 2021 | |
| Cardiva Medical, INC. | $17.95 | 2025 | Cardiva Vascade 6/7f Vcs |
| Horizon Therapeutics Plc | $15.17 | 2023 | Uplizna |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.